xanthenes has been researched along with Psychotic Disorders in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (91.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Battaglia, G; Britton, TC; Bruno, V; Cannella, M; Caraci, F; Copani, A; Drago, F; Giuffrida, ML; Heinz, BA; Merlo, S; Molinaro, G; Nicoletti, F; Nisenbaum, ES; Riozzi, B; Sortino, MA; Traficante, A; Wang, X | 1 |
| Radmayr, E | 1 |
| Padron, C | 1 |
| Rimestad, S | 1 |
| Gross, H; Kaltenbäck, E | 1 |
| Náhunek, K; Svestka, J | 1 |
| Edler, K; Gottfries, CG; Haslund, J; Ravn, J | 1 |
| dos Santos, LM; Ferreira, SC; Mariz, F; Mariz, P | 1 |
| Ravn, J | 1 |
| Hollister, LE | 1 |
| Brasseur, R | 1 |
| Angst, J; Hicklin, A | 1 |
2 trial(s) available for xanthenes and Psychotic Disorders
| Article | Year |
|---|---|
[Fluanxol in long-term treatment of psychotic patients].
Topics: Clinical Trials as Topic; Humans; Male; Psychotic Disorders; Schizophrenia; Tranquilizing Agents; Xanthenes | 1967 |
[Retrospective and prospective studies on the clinical effect of clopenthixol (sordinol) in endogenous phychoses].
Topics: Clopenthixol; Humans; Piperazines; Prospective Studies; Psychotic Disorders; Retrospective Studies; Tranquilizing Agents; Xanthenes | 1967 |
10 other study(ies) available for xanthenes and Psychotic Disorders
| Article | Year |
|---|---|
Targeting group II metabotropic glutamate (mGlu) receptors for the treatment of psychosis associated with Alzheimer's disease: selective activation of mGlu2 receptors amplifies beta-amyloid toxicity in cultured neurons, whereas dual activation of mGlu2 an
Topics: Alzheimer Disease; Amino Acids; Amyloid beta-Peptides; Animals; Antipsychotic Agents; Astrocytes; Bridged Bicyclo Compounds, Heterocyclic; Cells, Cultured; Mice; Mice, Knockout; Neurons; Neuroprotective Agents; Psychotic Disorders; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Reverse Transcriptase Polymerase Chain Reaction; Sulfonamides; Transforming Growth Factor beta1; Xanthenes | 2011 |
[Comparative study of Navane concentrate and tablets].
Topics: Adolescent; Adult; Female; Humans; Male; Middle Aged; Phenothiazines; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Tablets; Tranquilizing Agents; Xanthenes | 1968 |
[Clinical study of flupenthioxol (fluanxol)].
Topics: Adolescent; Adult; Ethanol; Female; Humans; Male; Middle Aged; Piperazines; Psychotic Disorders; Xanthenes | 1972 |
[Clinical treatment of chronic psychoses with flupenthixol-decanoate (Fluanxol-Depot)].
Topics: Adolescent; Adult; Aged; Chronic Disease; Delayed-Action Preparations; Ethanol; Hallucinations; Humans; Male; Middle Aged; Paranoid Disorders; Piperazines; Psychotic Disorders; Schizophrenia; Schizophrenia, Disorganized; Tranquilizing Agents; Xanthenes | 1972 |
Flupenthixol depot in the maintenance treatment of psychoses.
Topics: Adolescent; Adult; Aged; Basal Ganglia Diseases; Butyrophenones; Delayed-Action Preparations; Ethanol; Evaluation Studies as Topic; Fatigue; Female; Fluphenazine; Humans; Middle Aged; Piperazines; Psychotic Disorders; Recurrence; Sleep Initiation and Maintenance Disorders; Tranquilizing Agents; Xanthenes | 1972 |
Eye changes in connection with neuroleptic treatment especially concerning phenothiazines and thioxanthenes.
Topics: Adult; Age Factors; Aged; Cataract; Chlorpromazine; Cornea; Evaluation Studies as Topic; Eye Diseases; Female; Humans; Iris; Male; Middle Aged; Phenothiazines; Psychotic Disorders; Sex Factors; Tranquilizing Agents; Xanthenes | 1971 |
[Study of a new thioxanthene derivative in the treatment of psychoses].
Topics: Adolescent; Adult; Female; Humans; Male; Middle Aged; Psychotic Disorders; Tranquilizing Agents; Xanthenes | 1970 |
[10 years of therapeutic experience using thioxanthene derivates].
Topics: Amitriptyline; Chlorprothixene; Clopenthixol; Humans; Neurotic Disorders; Nortriptyline; Psychotic Disorders; Tranquilizing Agents; Xanthenes | 1970 |
Choice of antipsychotic drugs.
Topics: Butyrophenones; Drug Synergism; Drug Tolerance; Haloperidol; Humans; Phenothiazines; Piperazines; Piperidines; Psychopharmacology; Psychotherapy; Psychotic Disorders; Thioridazine; Thiothixene; Tranquilizing Agents; Triflupromazine; Xanthenes | 1970 |
[Preliminary study corncerning the treatment of chronic psychoses with Flupenthixol decanoate].
Topics: Administration, Oral; Adolescent; Adult; Chronic Disease; Electroencephalography; Ethanol; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Piperazines; Psychotic Disorders; Schizophrenia; Xanthenes | 1971 |